+ All Categories
Home > Business > Pharmapendium an introduction 29 feb2012

Pharmapendium an introduction 29 feb2012

Date post: 11-Jun-2015
Category:
Upload: ann-marie-roche
View: 852 times
Download: 0 times
Share this document with a friend
Description:
Pharmapendium is the only online resource for searching all drug approval review and correspondence documentation since 1938 (FDA/CDER/FOI archived FDA/ EMA EPAR approval document database), giving you unrivalled insights into the entire history of drug development and comparative data in preclinical, clinical and post-marketing phases.In this webinar we:- Showed you how your peers are using Pharmapendium to successfully move drugs along the pipeline.- Demonstrated how you can be “Better informed” and what this really means to you and your colleagues.
Popular Tags:
14
Welcome to our PharmaPendium Webinar! PharmaPendium, for informed drug development decisions – An introduction Your host: Chris Flemming Your presenter: Phil MacLaughlin
Transcript
Page 1: Pharmapendium an introduction 29 feb2012

Welcome to our PharmaPendium Webinar!

PharmaPendium, for informed drug development decisions – An introduction

Your host: Chris Flemming Your presenter: Phil MacLaughlin

Page 3: Pharmapendium an introduction 29 feb2012

Webinar control panel:

‘chat’ or ‘ask a question’ for questions

and comments

Option for full screen view

Q&A after presentation

Need to know

Page 4: Pharmapendium an introduction 29 feb2012

4

What is PharmaPendium?Key product points: Unique content

First product to offer both searchable FDA approval packages and EMA EPARs

• 1.9M newly-searchable pages covering all of FDA history, over 70 years (from 1938),• Searchable EMA EPAR content (from 1995)

Used primarily for Preclinical assessment (Safety, PK, Efficacy) and Regulatory Affairs

Other key sources: •EMA, •AERS (post-marketing events)

Page 5: Pharmapendium an introduction 29 feb2012

5

What is PharmaPendium?Extracted Data

First product to bring together preclinical, clinical & post marketing data

•Normalized terminology on searches, extracted data•Which experimental data translates, why or why not?

Over 1,100,000 extracted drug safety observations•Normalized AE/Tox terminology mapped to Class, Target, Structural Chemistry

Over 1,300,000 extracted PK parameter data, preclinical and clinical. Normalized and related the same way (structure, class, target)

Page 6: Pharmapendium an introduction 29 feb2012

6

FDA Approval Packages:Examples of original documents

Page 7: Pharmapendium an introduction 29 feb2012

7

OCR Example

Page 8: Pharmapendium an introduction 29 feb2012

8

FDA Approval PackageSearch result

Page 9: Pharmapendium an introduction 29 feb2012

Pharmacokinetic Module

Project Title

Unprecedented access to Preclinical and Clinical exposure data extracted from FDA packages (current & historic) and EMEA documents.

• preclinical and clinical exposure data at multiple parameters and usually under various experimental conditions:

• Concomitant drugs, disease states, demographic differences, etc.

• The level of PK data to be contained in this database is almost never published (competitive reasons) at this level of detail.

Pharmacokinetics, preclinical and clinical, & Drug Safety databases browsable within the same platform.

Page 10: Pharmapendium an introduction 29 feb2012

PK Module content sources

Project Title

Over 1,000,00 Extracted parameter values from (Every 2 mos.):• FDA Reviews from 1938-Present (FDA Approval Packages)• EMEA EPARs from ~ 1995 – Present

• With filterable fields and special designations for:• Drug name, Species, Study Group (population), Dose,

Route, Parameter, Value (normalized in searching), SD• Enantiomers, Metabolites, Tissue-specific studies,

Concomitants (Food Effects)

Page 11: Pharmapendium an introduction 29 feb2012

11

Let’s take a look at PharmaPendium

….by going to www.pharmapendium.com

Page 12: Pharmapendium an introduction 29 feb2012

12

POLL

The poll should appear on your screen shortly….

Page 13: Pharmapendium an introduction 29 feb2012

Questions & Answers

Page 14: Pharmapendium an introduction 29 feb2012

Q&A will be sent to you by email.

For more information and questions please contact [email protected]

Go to www.trainingdesk.elsevier.com/pharmapendium for all training related materials.

Please fill out the survey that appears on your screen after

leaving the webinar.

Please fill out the survey that appears on your screen after

leaving the webinar.


Recommended